July 25, 2005 08:01 ET

Pall Awarded Long-Term Contract from American Red Cross for Leukoreduction Filter Systems

EAST HILLS, N.Y.--(CCNMatthews - Jul 25, 2005) -

Pall Corporation (NYSE: PLL) announced today the signing of a new long-term agreement with the American Red Cross (ARC) to provide blood collection systems incorporating its proprietary filtration and venting technology. Financial terms of the agreement were not disclosed. Approximately 14 million units of blood are collected in the United States annually.

"This is a major contract for our Leukotrap™ family of filter systems as the Red Cross is one of the largest suppliers of blood and blood products in the U. S.," says Allan Ross, President of Pall Medical. ARC currently collects about 6 million units of blood annually.

Leukoreduction is the removal of contaminating white blood cells from blood products. Pall developed leukocyte reduction filters in the late 1980s and is the leading provider of these systems worldwide. These filter systems continue to play a pivotal role in improving patient outcomes and controlling health care costs. The Company offers the broadest portfolio of filtration systems that remove leukocytes from red cells, plasma and platelets providing customers with maximum flexibility in the manufacturing of life-saving blood products.

About Pall Corporation

Pall Corporation is the global leader in the rapidly growing field of filtration, separations and purification. Pall's business is organized around two broad markets: Life Sciences and Industrial. The Company provides leading-edge products to meet the demanding needs of customers in biotechnology, pharmaceuticals, transfusion medicine, semiconductors, water purification, aerospace and broad industrial markets. Total revenues for fiscal 2004 were $1.8 billion. The Company headquarters are in East Hills, New York, with extensive operations throughout the world. Visit Pall at

Forward-Looking Statements

This release contains "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995. These statements are based on current Company expectations and are subject to risks and uncertainties which could cause actual results to differ materially. Such risks and uncertainties include, but are not limited to: fluctuations in foreign currency exchange rates; regulatory approval and market acceptance of new technologies; changes in product mix and product pricing and in interest rates and cost of raw materials; the Company's success in enforcing its patents and protecting its proprietary products and manufacturing techniques and its ability to achieve the savings anticipated from its cost reduction initiatives; global and regional economic conditions and legislative, regulatory and political developments; and domestic and international competition in the Company's global markets. Additional information regarding these and other factors is available on the Web at and is included in the Company's reports filed with the U.S. Securities and Exchange Commission. Copies of such reports can be obtained, without charge, at

Management uses certain non-GAAP measurements to assess Pall's current and future financial performance. The non-GAAP measurements do not replace the presentation of Pall's GAAP financial results. These measurements provide supplemental information to assist management in analyzing Pall's financial position and results of operations. Pall has chosen to provide this information to facilitate meaningful comparisons of past, present and future operating results and as a means to emphasize the results of on-going operations.

Contact Information